Oncomine Focus Assay - MII IG Kerndatensatz-Modul Molekulares Tumorboard v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

DeviceDefinition: Oncomine Focus Assay

German

Profile: MII PR MTB Panel DeviceDefinition

MII EX MTB Panel Gene List
geneList: MII VS MTB Panel OFA
scope: SNV-Detektion

MII EX MTB Panel Gene List
geneList: MII VS MTB Panel OFA
scope: Fusions-Detektion

manufacturer: Thermo Fisher Scientific

DeviceNames

Name

Type

Oncomine Focus Assay

User Friendly name

type: Genpanel

capability
type: SNV-Detektion

capability
type: Fusions-Detektion

url: https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/DeviceDefinition/mii-dd-mtb-panel-ofa

onlineInformation: https://www.thermofisher.com/de/de/home/clinical/preclinical-companion-diagnostic-development/oncomine-oncology/oncomine-focus-assay.html

note:

DNA + RNA, 52 Gene; SNVs + Fusionen.

IG © 2024+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.mtb#2027.0.0-ballot.1 basiert auf FHIR 4.0.1. Erstellt 2026-09-15
Links: Inhaltsverzeichnis | QA-Bericht | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Impressum
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.